Repligen
RGEN
#2270
Rank
$8.40 B
Marketcap
$149.37
Share price
-4.48%
Change (1 day)
-10.13%
Change (1 year)
Categories

Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Volume in USD (price x number of shares), data since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025$21.87 M-36.33%
2024$34.35 M-68.17%
2023$0.10 B60.05%
2022$67.43 M90.89%
2021$35.32 M-76.42%
2020$0.14 B197.63%
2019$50.34 M-29.09%
2018$70.99 M835.37%
2017$7.59 M22.08%
2016$6.21 M-19.68%
2015$7.74 M-7.23%
2014$8.34 M721.71%
2013$1.01 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
$56.21 M$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
$8.2 M$70.05 M๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
$16.57 M$0.51 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$31.05 M$81.93 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
$0.39 M$8.1 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
$15.56 M$63.4 M๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$5.02 M$30.19 M๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
$9.3 M$18.92 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$8.34 M$13.64 M๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
$84.22 M$0.15 B๐Ÿ‡บ๐Ÿ‡ธ USA